EVRENZO
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for EVRENZO, covering 2025-07-25 to 2026-04-10. Get the full timeline:
Most recent: EMA Authorised: Evrenzo (roxadustat) — Astellas Pharma Europe B.V.
2 regulatory and trial events tracked for EVRENZO, covering 2025-07-25 to 2026-04-10. Get the full timeline:
Most recent: EMA Authorised: Evrenzo (roxadustat) — Astellas Pharma Europe B.V.